Our latest paper is out in Clinical Neurology & Neurosurgery We conducted a meta analysis on ML models predicting recurrence in HGG. Huge thanks to Hamid Borghei-Razavi, MD, FACS for his constant mentorship, and to my co-authors, esp. Bardia Hajikarimloo, M.D & Ali Mortezaei doi.org/10.1016j.cline…

New study comparing Onyx, Squid, and n-BCA for MMA embolization in cSDH just out in Neuroradiology! Very grateful to our amazing team! Nadir Al-Saidi Khaled M. Taghlabi, MD Bardia Hajikarimloo, M.D Ibrahim Mohammadzadeh Redi Rahmani Visish M. Srinivasan, MD Jan-Karl Burkhardt, MD & Amir Faraji, MD, PhD Link:B2n.ir/eh9832

In the Journal of Neuro-Oncology, the Stanford neurosurgery team studied PIK3CA-mutated meningiomas looking at targeted therapy approaches.

New paper out in Neuroradiology : “Can machine learning predict hematoma progression after TBI?” A meta-analysis showing AI’s edge in clinical decision-making. Read here: doi.org/10.1007/s00234… #AI #MachineLearning #TBI #Neuroradiology

Our systematic review & meta-analysis on stereotactic radiosurgery for petroclival meningiomas is now published in Acta Neurologica Belgica! 📌 94% LTC 📌 87–94% PFS 📌 5% complication rate SRS is effective & safe as both primary and adjuvant treatment. 🔗 doi.org/10.1007/s13760…

Our systematic review & meta-analysis on stereotactic radiosurgery for pituitary metastases is now published in BMC Radiation Oncology! 📌 92% local control 📌 77% cranial nerve improvement 📌 2% complication rate SRS is effective & safe—but limited in endocrine recovery. 🔗

Our systematic review & meta-analysis on ML models predicting EGFR status in NSCLC brain metastases is now published in BMC Cancer! 📌 AUC 0.91 📌 Accuracy 0.82 📌 Sensitivity 0.87 | Specificity 0.86 ML offers a non-invasive path to EGFR prediction. 🔗 doi.org/10.1186/s12885…

Our systematic review & meta-analysis evaluated outcomes of stereotactic radiosurgery (SRS) for tumor-related trigeminal neuralgia (TRTN) across 19 studies (n=454). 📌 73% achieved adequate pain relief 📌 38% became completely pain-free 📌 14% experienced adverse radiation

Our systematic review & meta-analysis on postoperative SRS for intracranial SFT/HPCs (n=228) reveals: 📌 94% 1-year local tumor control 📌 85% 5-year overall survival 📌 6% adverse radiation effect SRS offers a safe, effective adjuvant strategy for these rare aggressive tumors.

Just published in World Neurosurgery! Our SRMA evaluates ML-based models for preop differentiation of spinal schwannomas vs meningiomas (n=644). 📌 AUC = 0.944 📌 Sensitivity = 91% 📌 Specificity = 92% ML tools show strong diagnostic power—supporting surgical decision-making. 🔗

Our new paper on ML-based prediction of pituitary adenoma recurrence just published in BMC Endocrine Disorders! Grateful to Dr Hamid Borghei-Razavi, MD, FACS , Dr Michael Karsy MD PhD MSc FAANS FCNS , Dr Bardia Hajikarimloo, M.D and Dr Mohammadmahdi Sabahi for their incredible supports and collaborations. doi.org/10.1186/s12902…

Our new study is out in Endocrine We reviewed how machine learning models can predict post-op remission in pituitary adenoma. Huge thanks to Dr. Ricardo J Komotar ,Daniel Aaronson, MD ,Ahmet Günkan, MD ,Bardia Hajikarimloo, M.D , Ali Mortezaei and Vratko Himič 📎 doi.org/10.1007/s12020…

Thrilled to share our new publication in Neurosurgical Review! AI as predictors of meningioma recurrence: & meta-analysis. Grateful for the valuable support of Hamid Borghei-Razavi, MD, FACS , Bardia Hajikarimloo, M.D & Abdul. 🔗 doi.org/10.1007/s10143… #Neurosurgery #AI #Radiomics #BrainTumor

Hot off the press! Radial-first approach is shaping neuroendovascular practice. But which radial-specific catheter delivers? Special thanks to Drs Starke_neurosurgery, Amir Faraji, MD, PhD, & Redi Rahmani for their guidance and to team for their excellent work. Link:link.springer.com/article/10.100…

Now online Neuroradiology! FRED-X for aneurysms achieved 86% occlusion, <1% mortality, and 1.2% stenosis. Grateful to our incredible team! Starke_neurosurgery Amir Faraji, MD, PhD Redi Rahmani David Altschul Alex Hoang Muhammed Amir Essibayi, MD MSc Khaled M. Taghlabi, MD Terumo Neuro. Link:link.springer.com/article/10.100…

What do pooled results from DMVO trials really show? Please read findings in our latest paper. Special thanks to Dr Visish M. Srinivasan, MD for supervision and to team for great work! Redi Rahmani Amir Faraji, MD, PhD Vivek Yedavalli, MD, MS, FAHA Joshua Catapano Jan-Karl Burkhardt, MD Khaled M. Taghlabi, MD Link:link.springer.com/article/10.100…

Nadir Al-Saidi Ibrahim Mohammadzadeh Bardia Hajikarimloo, M.D NeuroNews AANS American_Stroke CNS UofL Neurosurgery Penn Neurosurgery Mohammad Amin Habibi

🎉🎉New in Neuroradiology! 📖 Systematic review & meta-analysis comparing MMA embolization + surgery vs. surgery alone for chronic subdural hematoma. 👏 to our team, particularly Ibrahim Mohammadzadeh Read here 👉 bit.ly/4hjhnIr #Neurosurgery #Neuroradiology

Excited to share our new paper on MMAE+ Surgery vs. Standalone Surgery for CSDH , in Neuroradiology , Huge thanks to my mentor Pascal Jabbour MD, FAANS, FACS, FAHA and Ahmet Günkan, MD and my dear friend Bardia Hajikarimloo, M.D , and all co-authors for their support. Grateful for this team! 🙏 #Neurosurgery #MMAE

Excited to share that our paper on AI predicting hematoma expansion in ICH is officially published! 🎉 Huge thanks to Pascal Jabbour MD, FAANS, FACS, FAHA , Ahmet Günkan, MD and Adam Dmytriw for their guidance, and to Bardia Hajikarimloo, M.D ,Mohammad Amin Habibi & the entire team for their hard work , #Neurosurgery